Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial

Cost Effectiveness of Sirolimus Eluting Stents vs. Vasculary Brachytherapy for In-Stent Restenosis: Results from the SISR Trial. American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. 2007.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.